Doximity, Inc. $DOCS Shares Purchased by Csenge Advisory Group

Csenge Advisory Group raised its stake in Doximity, Inc. (NASDAQ:DOCS) by 91.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 26,971 shares of the company’s stock after buying an additional 12,852 shares during the quarter. Csenge Advisory Group’s holdings in Doximity were worth $1,973,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. Royal Bank of Canada lifted its holdings in shares of Doximity by 24.2% in the 1st quarter. Royal Bank of Canada now owns 106,845 shares of the company’s stock worth $6,200,000 after acquiring an additional 20,847 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Doximity by 0.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock valued at $2,262,000 after purchasing an additional 210 shares during the last quarter. NewEdge Advisors LLC raised its position in Doximity by 613.7% in the first quarter. NewEdge Advisors LLC now owns 6,323 shares of the company’s stock valued at $367,000 after purchasing an additional 5,437 shares during the period. Goldman Sachs Group Inc. lifted its stake in Doximity by 33.3% during the first quarter. Goldman Sachs Group Inc. now owns 255,529 shares of the company’s stock worth $14,828,000 after purchasing an additional 63,873 shares in the last quarter. Finally, Focus Partners Wealth purchased a new position in shares of Doximity during the first quarter worth $283,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

DOCS has been the topic of several research analyst reports. Truist Financial set a $62.00 price objective on Doximity in a report on Thursday, January 8th. Canaccord Genuity Group set a $48.00 target price on Doximity in a research report on Thursday, January 8th. Morgan Stanley raised shares of Doximity from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $62.00 to $65.00 in a research report on Monday, December 15th. Barclays assumed coverage on shares of Doximity in a report on Monday, December 8th. They issued an “overweight” rating and a $63.00 price objective for the company. Finally, BMO Capital Markets initiated coverage on shares of Doximity in a research note on Thursday, November 13th. They set a “market perform” rating and a $55.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Doximity presently has a consensus rating of “Moderate Buy” and an average price target of $66.11.

Doximity Trading Up 0.5%

Shares of DOCS opened at $41.25 on Friday. The firm has a market capitalization of $7.77 billion, a price-to-earnings ratio of 41.25, a PEG ratio of 4.10 and a beta of 1.39. The firm’s fifty day simple moving average is $46.35 and its 200-day simple moving average is $59.12. Doximity, Inc. has a twelve month low of $39.95 and a twelve month high of $85.21.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, November 6th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the firm earned $0.30 EPS. The firm’s quarterly revenue was up 23.2% on a year-over-year basis. On average, analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Activity at Doximity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $66.44, for a total transaction of $132,880.00. Following the sale, the director owned 19,839 shares of the company’s stock, valued at approximately $1,318,103.16. This trade represents a 9.16% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 31.30% of the company’s stock.

Doximity Profile

Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.